• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TUTOGEN MEDICAL GMBH DURAFLEX DURAL GRAFT; BOVINE PERICARDIUM DURAL SUBSTITUTE GRAFT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TUTOGEN MEDICAL GMBH DURAFLEX DURAL GRAFT; BOVINE PERICARDIUM DURAL SUBSTITUTE GRAFT Back to Search Results
Lot Number NZ18450064
Device Problem Degraded (1153)
Patient Problem Cerebrospinal Fluid Leakage (1772)
Event Type  Injury  
Manufacturer Narrative
The xenograft was not available to return for inspection as it remains implanted.Therefore, a comprehensive re-review of manufacturing records, quality control/assurance reviews and release, and complaint database for related complaints associated with the lot was conducted.There were no departures noted during records re-review that would negatively affect the manufacturing of xenografts from lot nz18450064.All bovine pericardium implants undergo a validated sterilization method (tutoplast® which includes terminal sterilization by gamma irradiation after packaging).Manufacturing records indicate that all xenografts implants manufactured from this lot met all specifications and release criteria prior to distribution.To date, rti has manufactured and distributed a total of 11 xenograft implants, without related complaints for the lot.Additional information is needed to better understand and possibly explain the complications reported, including information regarding the preparation of the xenograft prior to implantation, suture procedure and suture material utilized, whether the graft was fixed under tension, and whether the patient has an allergy to bovine collagen and/or bovine material.
 
Event Description
Rti surgical, inc (rti) received an adverse event complaint from (b)(4) on 08/11/2020 the reported complaint indicated that the graft dissolved post transplantation.Additional information has been requested from (b)(4) (distributor) and the facility.To date, no additional information has been received.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
DURAFLEX DURAL GRAFT
Type of Device
BOVINE PERICARDIUM DURAL SUBSTITUTE GRAFT
Manufacturer (Section D)
TUTOGEN MEDICAL GMBH
industriestr 6
neunkirchen am brand, 91077
GM  91077
Manufacturer Contact
leila kelly
11621 research circle
alachua, FL 32615
3864188888
MDR Report Key10515585
MDR Text Key206508024
Report Number3002719998-2020-00008
Device Sequence Number1
Product Code GXQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K132850
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Nurse
Type of Report Initial
Report Date 09/10/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/10/2020
Is this an Adverse Event Report? Yes
Device Operator Health Professional
Device Lot NumberNZ18450064
Is the Reporter a Health Professional? Yes
Date Manufacturer Received08/11/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Other;
-
-